Source: DGNews  |  Posted 8 years ago

By Jerry Ingram

ORLANDO, FL -- October 27, 2003 -- Patients with rheumatoid arthritis (RA) appear to respond to treatment with adalimumab (Humira) as quickly as after 1 week of treatment, according to research from a clinical trial presented here on October 25th at the Annual Scientific Meeting of the American College of Rheumatology.

"You get early response in most patients -- 1 to 2 weeks. Those people who respond well respond early and the good responders continue to improve over time," said Daniel Furst, MD, lead researcher, Professor of Rheumatology, University of California